<DOC>
	<DOCNO>NCT00483431</DOCNO>
	<brief_summary>Earlier study show high vitamin K-intake lead improve bone vascular health increase carboxylation Gla-proteins tissue . From K-vitamins , menaquinone-7 ( MK-7 ) identify effective cofactor carboxylation reaction Gla-proteins osteocalcin matrix-gla protein . The question remain dosage MK-7 lead optimal carboxylation level protein . The primary objective double-blind randomize intervention study establish optimal dose MK-7 carboxylation vitamin K-dependent protein osteocalcin bone matrix-gla protein vessel wall . The optimal dose concentration osteocalcin matrix-gla protein &gt; 90 % active ( =carboxylated ) form .</brief_summary>
	<brief_title>Dose-Finding Study Vitamin K2 Human Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin K</mesh_term>
	<mesh_term>Vitamin K 2</mesh_term>
	<mesh_term>Vitamin MK 7</mesh_term>
	<criteria>Healthy male female adult 18 45 year age . Subjects normal body weight height accord BMI &lt; 30 Subject give write consent take part study Subjects ( history ) metabolic gastrointestinal disease Subject ( history ) soy allergy Subjects use vitamin supplement contain vitamin K Subjects present chronic inflammatory disease Subjects receive systemic treatment topical treatment likely interfere evaluation study parameter Subjects receive corticoÏŠd treatment Subjects use oral anticoagulant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>vitamin K2</keyword>
	<keyword>dosis-response</keyword>
	<keyword>osteocalcin</keyword>
	<keyword>matrix-gla protein</keyword>
</DOC>